Come up with a name for your new list and we'll add to it:
ReFissa raised a round of funding on February 02, 2017. Investors include
ZO Skin Health.
ReFissa 0.05% is a prescription medicine, developed by Suneva Medical, that may reduce fine facial wrinkles and mottled hyperpigmentation in patients who also protect their skin from the sun and wear …